Publications To Date


    Filter Publications

    PAGE 1 OF 96 | DISPLAYING 1 - 15 OF 1434 RESULTS

    Ryall S et al., Pediatric low-grade glioma in the era of molecular diagnostics., , Acta Neuropathol Commun, Jul 15, 2020

    Santos PM et al., Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses., , J Exp Med, Jul 06, 2020

    Cervera-Carrascon V et al., Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors., , Mol Ther Oncolytics, Jun 26, 2020

    Chiabotto G, Grignani G, Todorovic M, Aglietta M, D'Ambrosio L, Pignochino Y Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights., , Cancers (Basel), Jun 11, 2020

    Sarkozy C, Chong L, Takata K, Chavez EA, Miyata-Takata T, Duns G, Telenius A, Boyle M, Slack GW, Laurent C, Farinha P, Molina TJ, Copie-Bergman C, Damotte D, Salles GA, Mottok A, Savage KJ, Scott DW, Traverse-Glehen A, Steidl C. Gene expression profiling of gray zone lymphoma., , Blood Adv, Jun 10, 2020

    Lozano E, Mena MP, Díaz T, Prat A, Rosinol L, Fernández de Larrea C Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma., , Clin Cancer Res, Jun 09, 2020

    Vadakekolathu J et al., Immune Landscapes Predict Chemotherapy Resistance and Immunotherapy Response in Acute Myeloid Leukemia, , Sci Transl Med, Jun 03, 2020

    Kim ST, Hong JY, Park SH, Nam DH, Lee JW, Park K, Kim KM, Lee J First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients., , Ther Adv Med Oncol, Jun 03, 2020

    Bergamaschi C, Pandit H, Nagy BA, Fox BA, Felber BK, Pavlakis GN Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10., , J Immunother Cancer, May 30, 2020

    Olkhov-Mitsel E, Hodgson A, Liu SK, Vesprini D, Bayani J, Bartlett J, Xu B, Downes MR Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study., , J Clin Pathol, May 30, 2020

    Millstein J, Budden T, Goode EL, Doherty JA, Pharoah PDP, Ramus SJ Prognostic gene expression signature for high-grade serous ovarian cancer., , Ann Oncol, May 28, 2020

    McCart Reed AE, Bennett J, Kutasovic JR, Yeong J, Simpson PT, Lakhani SR Digital spatial profiling application in breast cancer: a user's perspective., , Virchows Arch, May 27, 2020

    Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, Munro SA, Tiegs L, McCarthy JB, Nelson AC, Schwertfeger KL. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer., , Cancers (Basel), May 23, 2020

    Rock AN, Fisher MD, Amborski G, Allain DC, Klee V, Peters SB, Kang S, Toland AE MicroRNA Expression Profiling of Cutaneous Squamous Cell Carcinomas Arising in Different Sites., , Otolaryngol Head Neck Surg, May 20, 2020

    Hillen LM, Geybels MS, Spassova I, Becker JC, Gambichler T, Garmyn M, zur Hausen A, van den Oord J, Winnepenninckx V A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms., , FEBS Open Bio, May 20, 2020